Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Improvement of small molecule ClpP activators for use in hybrid antibiotics

Award Number: F31AI194772
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 09/01/2025
PERIOD OF PERFORMANCE END DATE: 08/31/2028

Group Awards By:

View Award Description

Improvement of small molecule ClpP activators for use in hybrid antibiotics - Project Summary Antibiotic-resistant pathogens are an ongoing clinical crisis as multi-drug resistance increases the rate of treatment failure. Staphylococcus aureus (S. aureus), a Gram-positive pathogen, is considered a serious threat by the CDC due to the emergence of resistant populations and its propensity to form biofilms, limiting the antibiotics that can be used for treatment. Patient populations with compromised immune systems, such as those here at St. Jude Children’s Research Hospital, are at a high risk of developing biofilm infections through implanted devices that are administering lifesaving care. A class of natural products, the acyldepsipeptides (ADEPs) have activity against biofilm infections due to their ability to activate caseinolytic protease subunit P (ClpP), a non-essential conserved protease in Gram-positive bacteria. ADEP binding displaces the ATP- regulated chaperone protein, leading to uncontrolled proteolysis and cell death. Previous work in our lab has generated a ureadepsipeptide (UDEP), which improves the stability, selectivity, and potency of the original ADEP. However, the high mutation frequency of ClpP limits its use as an antibiotic target. When co-dosing ClpP activators with rifampin, there is a drastic reduction in the emergence of resistance and an additive decrease in bacterial burden in vivo. To better control tissue distribution, our lab conjugated the lead UDEP compound to rifampin to generate a hybrid compound called chimerabactin. Chimerabactin has dual-target engagement and decreased resistance rates in S. aureus, but the molecule requires a complicated synthesis route with a minimum of 21 steps and is over 25 Å in size, so there is an imminent need for structural modifications. I propose an approach in which we improve on a small molecule ClpP activator series and establish the feasibility of using this series instead of the UDEP compound. I will use computational modeling and QSAR studies to inform chemical design before synthesis and validation using previously established workflows in the lab.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $48,538 )
2025	2025	ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC	262 DANNY THOMAS PL # 1500	MEMPHIS	TN	38105	SHELBY	USA	Allergy and Infectious Diseases Research	001	1	8/1/2025	NEW	$0
2025	2025	ST. JUDE CHILDREN'S RESEARCH HOSPITAL GRADUATE SCHOOL OF BIOMEDICAL SCIENCES, LLC	262 DANNY THOMAS PL # 1500	MEMPHIS	TN	38105	SHELBY	USA	Allergy and Infectious Diseases Research	000	1	8/1/2025	NEW	$48,538
														Subtotal = $48,538

Grand Total All Awards = $48,538

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Improvement of small molecule ClpP activators for use in hybrid antibiotics

Award Number: F31AI194772

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 09/01/2025

PERIOD OF PERFORMANCE END DATE: 08/31/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer